Mira Pharmaceuticals Inc (NASDAQ: MIRA) open the trading on Wednesday, with a bit cautious approach as it glided -12.24% to $1.72, before settling in for the price of $1.96 at the close. Taking a more long-term approach, MIRA posted a 52-week range of $0.51-$6.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 15.62%. This publicly-traded company’s shares outstanding now amounts to $14.78 million, simultaneously with a float of $9.52 million. The organization now has a market capitalization sitting at $25.42 million. At the time of writing, stock’s 50-day Moving Average stood at $1.5496, while the 200-day Moving Average is $1.3347.
Mira Pharmaceuticals Inc (MIRA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Mira Pharmaceuticals Inc’s current insider ownership accounts for 35.60%, in contrast to 4.82% institutional ownership. According to the most recent insider trade that took place on May 21 ’24, this organization’s Chief Executive Officer bought 8,700 shares at the rate of 0.94, making the entire transaction reach 8,176 in total value, affecting insider ownership by 382,200. Preceding that transaction, on Dec 04 ’23, Company’s 10% Owner sold 61,331 for 3.98, making the whole transaction’s value amount to 244,097. This particular insider is now the holder of 723,062 in total.
Mira Pharmaceuticals Inc (MIRA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
Mira Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 15.62% and is forecasted to reach -0.57 in the upcoming year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
Let’s observe the current performance indicators for Mira Pharmaceuticals Inc (MIRA). It’s Quick Ratio in the last reported quarter now stands at 3.68. The Stock has managed to achieve an average true range (ATR) of 0.36.
In the same vein, MIRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.84, a figure that is expected to reach -0.15 in the next quarter, and analysts are predicting that it will be -0.57 at the market close of one year from today.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
[Mira Pharmaceuticals Inc, MIRA] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 22.74% While, its Average True Range was 0.3296.
Raw Stochastic average of Mira Pharmaceuticals Inc (MIRA) in the period of the previous 100 days is set at 26.89%, which indicates a major rise in contrast to 3.92% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 103.82% that was lower than 351.63% volatility it exhibited in the past 100-days period.
